Hosted on MSN
Achieve Life Sciences targets NDA submission for cytisinicline in June 2025 as open label study hits key milestones
CEO Rick Stewart stated that "Achieve is on track to submit the NDA for cytisinicline next month." He emphasized that "all internal resources are now focused on a successful NDA submission, acceptance ...
CEO Richard A. Stewart described the quarter as "another truly significant quarter for Achieve in our mission to get a new treatment for nicotine dependence into the hands of patients," highlighting ...
THIRUVANANTHAPURAM: The LDF government’s ambitious LIFE mission for the homeless will complete its target of five lakh houses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results